Loading…
A microfluidic chip for capturing, imaging and counting CD3+ T-lymphocytes and CD19+ B-lymphocytes from whole blood
•We propose a pillar-based microfluidic device to separate leukocytes from whole blood high efficiently without clogging.•We could obtain the count and ratio of T and B cells from whole blood and compared the results to those obtained using a flow cytometer.•We achieved 99.8% efficiency in capturing...
Saved in:
Published in: | Sensors and actuators. B, Chemical Chemical, 2018-12, Vol.276, p.107-113 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •We propose a pillar-based microfluidic device to separate leukocytes from whole blood high efficiently without clogging.•We could obtain the count and ratio of T and B cells from whole blood and compared the results to those obtained using a flow cytometer.•We achieved 99.8% efficiency in capturing leukocytes using the microfluidic chip,•The ratio of CD3+ and CD19+ had a coefficient of r = 0.9876 and a coefficient of variation of 2.77%, from 1 μL of whole blood sample.
We have designed and evaluated a simple and practical system for CD3+ (T-lymphocyte) and CD19+ (B-lymphocyte) cell counting on-chip using a PDMS microfluidic chip which captures these cells using a pillarbased filtration technique. Conventional pillar-based or membrane-based cell separation methods suffer from the problem of cell clogging, thereby reducing the separating and capturing efficiency of the device. To address these issues, we proposed a unique and simple design of a microfluidic chip with an escape route at the pillar-based cell filtration area in the chip which prevents cell clogging. Currently, the diagnosis, monitoring and treatment of immunodeficiency disorder require quantifying the leukocyte population, especially T-lymphocytes and Blymphocytes, in whole blood. We evaluated the performance of our microfluidic chip by obtaining the ratio of T-lymphocytes and Blymphocytes from whole blood and compared the results to those obtained using a flow cytometer. We confirmed that the cell capture area of the microfluidic chip remains clog-free. We achieved 99.8% efficiency in capturing leukocytes using the microfluidic chip, and the ratio of CD3+ and CD19+ had a coefficient of r = 0.9876 and a coefficient of variation (CV) of 2.77%, from 1 μL of whole blood sample. |
---|---|
ISSN: | 0925-4005 1873-3077 |
DOI: | 10.1016/j.snb.2018.08.063 |